0 seconds of 1 minute, 40 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
01:40
01:40
 
  • Tetra Bio-Pharma (TBP) has filed three patent applications for its novel therapeutic, ARDS-003
  • The patents will provide additional protection to investors for up to 20 years from the filing date
  • ARDS-003 is a novel First in Human (FIH) drug product developed to modulate acute systemic inflammation and prevent sepsis, ARDS, and organ damage
  • Guy Chamberland, CEO and Chief Regulatory Officer at Tetra sat down with Sabrina Cuthbert to discuss the news
  • Tetra Bio-Pharma is a leader in cannabinoid-derived drug discovery and development
  • Tetra Bio-Pharma Inc. (TBP) opened trading at C$0.025

Tetra Bio-Pharma (TBP) has filed three patent applications for its novel therapeutic, ARDS-003.

Guy Chamberland, CEO and Chief Regulatory Officer at Tetra, sat down with Sabrina Cuthbert to discuss the news.

“This is a significant step in protecting our novel therapeutic, ARDS-003. It is especially significant, considering the potential use of this novel cannabinoid molecule in antiviral and immunomodulator therapies. These patents would be enforceable once granted and provide additional protection to investors for up to 20 years from the filing date.”

ARDS-003 is a novel First in Human (FIH) drug product containing the active pharmaceutical agent, Onternabez, a potent and selective full agonist of the type 2 cannabinoid receptor (CB2R). ARDS-003 is positioned to modulate acute systemic inflammation and prevent sepsis, ARDS, and organ damage. 

Tetra Bio-Pharma is a leader in cannabinoid-derived drug discovery and development with an FDA and Health Canada-cleared clinical program to bring novel prescription drugs and treatments to patients and their healthcare providers.

Tetra Bio-Pharma Inc. (TBP) opened trading at C$0.025 per share.

More From The Market Online
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: Record profits, lawsuits, and acquisitions, oh my!

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks.
BriaCell logo

BriaCell’s Bria-OTS shows sustained success against breast cancer

BriaCell (TSX:BCT) announces the resolution of the lung metastasis first reported in February in a 78-year-old woman with breast cancer.

Buzz on the Bullboards: Quarterly success stories and struggles

Whitecap Resources, Aecon Group, and WELL Health Technologies have reported developments and results that could impact their performance.
Image via Hapbee Technologies Inc

Hapbee Technologies to rollout new ‘Boosted Signals’ feature

Hapbee Technologies (TSXV:HAPB) is rolling out a new feature—Boosted Signals—as part of the company’s redesigned mobile...